-The Hindu Without addressing undernutrition, the goals of reducing the incidence of TB, and mortality, in India, cannot be reached In the past, there was a belief that every ill had a pill and the pill killed the germs that made you ill. That germ could be a bacteria, virus or a parasite. Factors such as genetic and metabolic causes, hormonal imbalance and altered neuro-chemical transmitters causing illnesses were less known then....

-The Indian Express Innovation in vaccine production can have an impact only if it is accessible to all. Patents and access to life-saving drugs has always been an emotive and contentious issue. The right to healthy life is a moral minimum, and to find a rational basis to deny it is deeply offensive to the idea of life itself. At the same time, pharma corporations and institutions claim patents are a just...

-The Hindu Around the world, nearly 1.6 billion people are affected by a group of diseases so ignored that the term used to refer to them is called neglected tropical diseases (NTDs). These are a cluster of 17 diseases affecting the poorest people living in the least developed pockets of the world. While some of these diseases may be unfamiliar, leprosy, kala-azar and filariasis are better known in India and being targeted...

-Economic and Political Weekly Ten years on, the progressive provisions of the amended Indian Patents Act are being watered down. Ten years have passed since the Indian Patents Act, 1970 was amended in 2005 to bring the country’s laws in line with the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). The most important of the 2005 amendments was the introduction of product patents for 20 years, including for pharmaceutical products,...

-The Hindu Tropical diseases have often been neglected by pharmaceuticals because the size of the drug market is smaller, people have lower incomes and companies are uncertain about IPR January marked an important breakthrough in the fight against tropical diseases. Researchers and the International Centre for Genetic Engineering and Biotechnology (ICGEB) in Delhi found a drug candidate that prevented TB and malaria pathogens from infecting human blood cells. It is not just that...